Second-line tisagenlecleucel does not improve outcomes in B-cell lymphoma
1. Patients with B-cell non-Hodgkin's lymphoma receiving tisagenlecleucel did not show delayed lymphoma progression compared to those receiving standard salvage ...
1. Patients with B-cell non-Hodgkin's lymphoma receiving tisagenlecleucel did not show delayed lymphoma progression compared to those receiving standard salvage ...
Check out the original article from the Lancet Haematology here.
Umbilical cord blood (UCB) is a rich source of stem cells for transplantation in patients with hematologic malignancies. However, its ...
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer The risk of venous thromboembolism (VTE) is significantly increased in patients ...
1. In a retrospective review of over 7600 patients who previously underwent hematopoietic stem-cell transplantation, there was a significantly increased incidence of fractures ...
Image: PD 1. Hematopoeitic stem-cell transplant (HSCT) patients who received donor cells with a PTX3 haplotype of h2/h2 had an ...
Image: PD 1. The genome of a novel bacterium Bradyrhizobium enterica was discovered via gene sequencing in patients with cord ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.